Triple negative breast cancer (TNBC) is defined by the lack of expression of estrogen receptor (ER) and progesterone receptor (PR), and absence of ERBB2 (HER2) over expression and/or gene amplification and is associated with poor long-term outcomes compared to other breast cancer subtypes [1-3]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.